AdventHealth has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, known as the Ensemble trial, to evaluate the safety and efficacy of Janssen’s investigational COVID-19 vaccine candidate.
They are excited about this opportunity to contribute to the fight against the coronavirus pandemic, and our goal is to enroll 4,500 participants in Central Florida over an 8-week period.
COVID-19 has impacted minority communities and older adults at higher rates than other populations. Although it is not a study requirement to enroll a specific percentage of people of a particular age, race or ethnic background, they want to ensure that the population in this study is representative of the population most impacted by COVID-19.
People who are selected to participate will receive a single dose, either of the vaccine or a placebo. The vaccine (or placebo) will be administered to approved participants at the AdventHealth Orlando, East Orlando and Kissimmee campuses.
For more information, including how to apply for enrollment, go to AdventHealthVaccineTrials.com or call 844-422-2282.